NEU 0.58% $12.21 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1149

  1. 5,894 Posts.
    lightbulb Created with Sketch. 360
    Fair enough, KJT was asking for input re his valuations and discounts applied. But no one offered any variations on his numbers to demonstrate why a TO of say $50 was valid in the DCF model that NEU will be using in case of a TO. After perhaps 4 phase 2 trials, FDA guidance on phase 3 requirements, Daybue sales increasing and new territories opening up. As well as initial works on 4/6 new indications.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.21
Change
0.070(0.58%)
Mkt cap ! $1.560B
Open High Low Value Volume
$12.22 $12.32 $11.91 $4.990M 410.3K

Buyers (Bids)

No. Vol. Price($)
1 500 $12.14
 

Sellers (Offers)

Price($) Vol. No.
$12.22 1456 1
View Market Depth
Last trade - 16.10pm 23/12/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.